Tech Company Financing Transactions
Embrella Cardiovascular Funding Round
On 1/15/2008, Embrella Cardiovascular raised $2.3 million in Series A funding from BioStar Private Equity Fund, MedFocus Fund and private investors.
Transaction Overview
Company Name
Announced On
1/15/2008
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Series A
Proceeds Purpose
Company CEO Jeffrey O'Donnell commented, "We are grateful to the early stage investors and our individual investors for their participation in this initial round of funding. Embrella's Board is focused on accelerating the design and developmental phase of its device and committed to recruiting the brightest and best to ensure success."
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
880 E. Swedesford Road 220
Wayne, PA 19087
USA
Wayne, PA 19087
USA
Phone
Website
Email Address
Overview
Embrella Cardiovascular, Inc., based in Malvern, Pennsylvania, is an early stage company dedicated to developing a unique, proprietary system to enhance embolic cerebral protection, enabling interventionalists to reduce the frequency of embolic strokes during cardiovascular procedures.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jeffrey O'Donnell
Chief Scientific Officer
Jeffrey Carpenter
VP - Bus. Development
Carol Burns
Browse more venture capital transactions:
Prev: 1/15/2008: Centric Software venture capital transaction
Next: 1/15/2008: Silver Peak venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs